Wize Pharma

Wize Pharma Equity Growth

Delisted·Jan 10, 2019

The Year-over-Year Equity Growth of Wize Pharma (WIZP) as of Nov 19, 2026 is -875.33 %. In the previous year, Year-over-Year Equity Growth was 152.36 % — a change of -674.52% (lower).

Equity Growth

-875.33 %

YoY

-674.52%

Last updated:

Year-over-Year Equity Growth of Wize Pharma is 2020 -875.33 % . Year-over-Year Equity Growth of Wize Pharma was 2019 152.36 % . It decreases by -674.52% lower compared to the previous year.

The Wize Pharma Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2015
15,610.00 USD
Jan 1, 2016
-189.40 USD
Jan 1, 2017
25.53 USD
Jan 1, 2018
106.84 USD
Jan 1, 2019
152.36 USD
Jan 1, 2020
-875.33 USD
The Wize Pharma Equity Growth history
YEAREquity GrowthYoY
-875.33 %-674.52%
152.36 %+42.60%
106.84 %+318.52%
25.53 %-113.48%
-189.40 %-101.21%
15,610.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wize Pharma Stock analysis

What does Wize Pharma do? Wize Pharma Inc. is a leading biopharmaceutical company specializing in the development and marketing of innovative products for the treatment of eye diseases. The company was founded in 1997 and is headquartered in Herzliya Pituach, Israel. It focuses on the research, development, manufacturing, and marketing of eye disease treatments. The company aims to become a leading brand in the field of eye health and offers high-quality services in eye care. Wize Pharma Inc. operates different divisions, with its main divisions being the development and marketing of eye therapeutics, including LO2A and LO2B. LO2A is an innovative therapy for dry eye, while LO2B is an intraoperative formulation used in glaucoma surgery. The company's products provide effective and sustainable solutions for the treatment of eye diseases. Wize Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Wize Pharma stock

Year-over-Year Equity Growth of Wize Pharma is -875.33 % in 2020.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth Wize Pharma since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's Wize Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Wize Pharma

All Key Metrics — Wize Pharma